Eforto Health Inc.

Eforto Health develops the Eforto® System, a validated medical device and software platform for monitoring muscle strength, muscle fatigability, and self-perceived fatigue as biomarkers of vitality capacity (WHO definition). The company offers a comprehensive solution comprising the Eforto® Vigorimeter (an ergonomic handheld grip strength device with medical-grade pressure sensor and auto-calibration), a guided mobile app with validated protocols, and Eforto® Metrics for remote patient monitoring and insightful reporting. The system completes testing in under 5 minutes and supports self-testing at home with interactive app guidance. Core applications include clinical healthcare (disease management, rehabilitation decision-support), health and fitness (muscle health tracking), and clinical research with customizable protocols. The platform is trusted by major medical institutions including Kansas University Medical Center, Erasmus Medical Center, Radboud UMC, and VU Brussels. All data processing is HIPAA, GDPR, and ISO 27001 compliant with FHIR API interoperability. Clinical validation is published in The Lancet Healthy Longevity and Springer journals.